Seema Parvekar
Research Subjects
Seema Parvekar has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Archana Patel
Lata Medical Research Foundation, Nagpur, India
3 shared publications - Ashwini Patel
Lata Medical Research Foundation, Nagpur 440022, India
3 shared publications - Hemant Kulkarni
Lata Medical Research Foundation,Nagpur,India; M&H Research, LLC,San Antonio,USA, USA
3 shared publications - Kanchan V. Pipal
Lata Medical Research Foundation, Nagpur 440022, India
3 shared publications - Kunal Kurhe
Lata Medical Research Foundation,Nagpur,India, India
3 shared publications - Manisha Jaisinghani
Lata Medical Research Foundation, Nagpur 440022, India
3 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by MDPI AG in Preprints.org
Early Prediction of Gestational Diabetes Using Deep Learning and Electrocardiography: Results from the MERGD Study
Background: Current guidelines by the American College of Obstetrics and Gynecology require a two-step procedure for diagnosis of gestational diabetes (GD). This two-step procedure is challenging in resource limited settings. We determined if electrocardiography (ECG) done combined with artificial intelligence techniques can predict GD to provide a non-invasive, early gatekeeper strategy for GD risk stratification. Methods: Data for this study came from the Markers of Early Risk-stratification of Gestational Diabetes (MERGD) study and included 10s, 12-lead ECGs collected at the first antenatal visit. Patients were invited to undergo GCT at 24-28 weeks and, if required, an OGTT was conducted. GCT result was considered positive if the 1-hour, 50g glucose load blood glucose level was ≥130 mg/dL. ECGs were preprocessed, filtered, and a synthetic dataset was generated by using features from autoencoders, device-reported variables and heart rate variability parameters. A random forest model (RF-ECG) was trained on the synthetic data and validated first by 10-fold cross-validation, then on a held-out test of the synthetic data and finally on the original data not seen by the model. Results: Total 1,036 quality checked, preprocessed ECGs were used in the study. A total of 123 (11.87%) women developed GD. The fully trained RF-ECG model provided validation performance as follows: 78.28% accuracy, 87.80% sensitivity, 77.00% specificity and a likelihood ratio of positive test of 3.82. The RF-ECG model outperformed existing models of GD risk stratification. Importance metric identified 40 features as contributory to the model’s diagnostic logic. Conclusions: ECGs can accurately predict the likelihood of GD ahead of the final diagnosis. If supported by external validation in future studies, our approach can help noninvasively identify GD risk early during pregnancy in resource limited settings.
- 26 August 2026
- Published by MDPI AG in Preprints.org
Open AccessEarly Prediction of Gestational Diabetes Using Deep Learning and Electrocardiography: Results from the MERGD Study
Background: Current guidelines by the American College of Obstetrics and Gynecology require a two-step procedure for diagnosis of gestational diabetes (GD). This two-step procedure is challenging in resource limited settings. We determined if electrocardiography (ECG) done combined with artificial intelligence techniques can predict GD to provide a non-invasive, early gatekeeper strategy for GD risk stratification. Methods: Data for this study came from the Markers of Early Risk-stratification of Gestational Diabetes (MERGD) study and included 10s, 12-lead ECGs collected at the first antenatal visit. Patients were invited to undergo GCT at 24-28 weeks and, if required, an OGTT was conducted. GCT result was considered positive if the 1-hour, 50g glucose load blood glucose level was ≥130 mg/dL. ECGs were preprocessed, filtered, and a synthetic dataset was generated by using features from autoencoders, device-reported variables and heart rate variability parameters. A random forest model (RF-ECG) was trained on the synthetic data and validated first by 10-fold cross-validation, then on a held-out test of the synthetic data and finally on the original data not seen by the model. Results: Total 1,036 quality checked, preprocessed ECGs were used in the study. A total of 123 (11.87%) women developed GD. The fully trained RF-ECG model provided validation performance as follows: 78.28% accuracy, 87.80% sensitivity, 77.00% specificity and a likelihood ratio of positive test of 3.82. The RF-ECG model outperformed existing models of GD risk stratification. Importance metric identified 40 features as contributory to the model’s diagnostic logic. Conclusions: ECGs can accurately predict the likelihood of GD ahead of the final diagnosis. If supported by external validation in future studies, our approach can help noninvasively identify GD risk early during pregnancy in resource limited settings.
- Open Access
- 10 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7151
Opportunity Screening for Early Detection of Gestational Diabetes: Results from the MERGD Study
Background: The definitions and approaches used to diagnose gestational diabetes (GD) are varied. The two-step approach recommended by the American College of Obstetricians and Gynecologists (ACOG) combines the sensitivity of a glucose challenge test (GCT) with the specificity of a 3-hour oral glucose tolerance test (OGTT). We investigated if minor modification of the two-step procedure can provide improved detection of GD by identifying a risk group of pregnant women with high risk of GD. Methods: We conducted a prospective cohort study of pregnant women enrolled early during pregnancy and followed till delivery. All participants underwent the ACOG-recommended two-step procedure for GD diagnosis. Based on GCT and OGTT results, the participants were divided into four risk groups (RGs): GCT-negative (RG0), GCT-positive but OGTT normal (RG1), single abnormal value on OGTT or raised HbA1c (RG2) and diagnosed GD (RG3). Baseline evaluation included dietary history (24 hour recall) and physical activity. A series of multivariable logistic regression analyses were conducted to estimate the odds of maternal and fetal outcomes. Results: A total of 1041 pregnant women were included in the study, of whom 16 (1.6%) were diagnosed as GD. Our two-step approach identified 48 (4.6%) women as GD, while RG2, RG1 and RG0 comprised 75 (7.2%), 218 (20.9%) and 700 (67.2%), respectively. Compared to RG0, RG2 showed a higher likelihood of antepartum complications [odds ratio and 95% confidence interval 2.38 (1.16–4.15)], any adverse outcome without [2.04 (1.17–3.55)] or with cesarean section [2.09 (1.21–3.61)] and primary cesarean section [1.68 (1.01–2.81)] after adjustment for potential confounders. RG2 was also significantly associated with pregnancy-induced hypertension, meconium-stained amniotic fluid and premature rupture of membranes. Conclusions: In the study participants, we identified a subgroup (RG2) at high risk of GD with perinatal outcomes showing profile consistent with that of GD.
- 10 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7151
Open AccessOpportunity Screening for Early Detection of Gestational Diabetes: Results from the MERGD Study
Background: The definitions and approaches used to diagnose gestational diabetes (GD) are varied. The two-step approach recommended by the American College of Obstetricians and Gynecologists (ACOG) combines the sensitivity of a glucose challenge test (GCT) with the specificity of a 3-hour oral glucose tolerance test (OGTT). We investigated if minor modification of the two-step procedure can provide improved detection of GD by identifying a risk group of pregnant women with high risk of GD. Methods: We conducted a prospective cohort study of pregnant women enrolled early during pregnancy and followed till delivery. All participants underwent the ACOG-recommended two-step procedure for GD diagnosis. Based on GCT and OGTT results, the participants were divided into four risk groups (RGs): GCT-negative (RG0), GCT-positive but OGTT normal (RG1), single abnormal value on OGTT or raised HbA1c (RG2) and diagnosed GD (RG3). Baseline evaluation included dietary history (24 hour recall) and physical activity. A series of multivariable logistic regression analyses were conducted to estimate the odds of maternal and fetal outcomes. Results: A total of 1041 pregnant women were included in the study, of whom 16 (1.6%) were diagnosed as GD. Our two-step approach identified 48 (4.6%) women as GD, while RG2, RG1 and RG0 comprised 75 (7.2%), 218 (20.9%) and 700 (67.2%), respectively. Compared to RG0, RG2 showed a higher likelihood of antepartum complications [odds ratio and 95% confidence interval 2.38 (1.16–4.15)], any adverse outcome without [2.04 (1.17–3.55)] or with cesarean section [2.09 (1.21–3.61)] and primary cesarean section [1.68 (1.01–2.81)] after adjustment for potential confounders. RG2 was also significantly associated with pregnancy-induced hypertension, meconium-stained amniotic fluid and premature rupture of membranes. Conclusions: In the study participants, we identified a subgroup (RG2) at high risk of GD with perinatal outcomes showing profile consistent with that of GD.
- Open Access
- 26 August 2025
- Published by MDPI AG in Preprints.org
Opportunity Screening for Early Detection of Gestational Diabetes: Results from the MERGD Study
Background: The definitions and approaches used to diagnose gestational diabetes (GD) are varied. The two-step approach recommended by the American College of Obstetricians and Gynecologists (ACOG) combines the sensitivity of a glucose challenge test (GCT) with the specificity of a 3-hour oral glucose tolerance test (OGTT). We investigated if minor modification of the two-step procedure can provide improved detection of GD by identifying a risk group of pregnant women with high risk of GD. Methods: We conducted a prospective cohort study of pregnant women enrolled early during pregnancy and followed till delivery. All participants underwent the ACOG-recommended two-step procedure for GD diagnosis. Based on GCT and OGTT results, the participants were divided into four risk groups (RG)s: GCT negative (RG0), GCT positive but OGTT normal (RG1), single abnormal value on OGTT or raised HbA1c (RG2) and diagnosed GD (RG3). Baseline evaluation included dietary history (24-hour recall) and physical activity. A series of multivariable logistic regression analyses were conducted to estimate the odds of maternal and fetal outcomes. Results: A total of 1,041 pregnant women were included in the study of who 16 (1.6%) were diagnosed as GD. Our two-step approach identified 48 (4.6%) women as GD while the RG2, RG1 and RG0 groups comprised 75 (7.2%), 218 (20.9%) and 700 (67.2%), respectively. Compared to RG0, the RG2 group showed a higher likelihood of antepartum complications [odds ratio and 95% confidence interval 2.38 (1.16-4.15)], any adverse outcome without [2.04 (1.17-3.55)] or with cesarean section [2.09 (1.21-3.61)], and primary cesarean section [1.68 (1.01-2.81)] after adjustment for potential confounders. The RG2 group was also significantly associated with pregnancy induced hypertension, meconium-stained amniotic fluid and premature rupture of membranes. Conclusions: In the study participants, we identified a subgroup (RG2) at high risk of GD with perinatal outcomes showing profile consistent with that of GD.
- 26 August 2025
- Published by MDPI AG in Preprints.org
Open AccessOpportunity Screening for Early Detection of Gestational Diabetes: Results from the MERGD Study
Background: The definitions and approaches used to diagnose gestational diabetes (GD) are varied. The two-step approach recommended by the American College of Obstetricians and Gynecologists (ACOG) combines the sensitivity of a glucose challenge test (GCT) with the specificity of a 3-hour oral glucose tolerance test (OGTT). We investigated if minor modification of the two-step procedure can provide improved detection of GD by identifying a risk group of pregnant women with high risk of GD. Methods: We conducted a prospective cohort study of pregnant women enrolled early during pregnancy and followed till delivery. All participants underwent the ACOG-recommended two-step procedure for GD diagnosis. Based on GCT and OGTT results, the participants were divided into four risk groups (RG)s: GCT negative (RG0), GCT positive but OGTT normal (RG1), single abnormal value on OGTT or raised HbA1c (RG2) and diagnosed GD (RG3). Baseline evaluation included dietary history (24-hour recall) and physical activity. A series of multivariable logistic regression analyses were conducted to estimate the odds of maternal and fetal outcomes. Results: A total of 1,041 pregnant women were included in the study of who 16 (1.6%) were diagnosed as GD. Our two-step approach identified 48 (4.6%) women as GD while the RG2, RG1 and RG0 groups comprised 75 (7.2%), 218 (20.9%) and 700 (67.2%), respectively. Compared to RG0, the RG2 group showed a higher likelihood of antepartum complications [odds ratio and 95% confidence interval 2.38 (1.16-4.15)], any adverse outcome without [2.04 (1.17-3.55)] or with cesarean section [2.09 (1.21-3.61)], and primary cesarean section [1.68 (1.01-2.81)] after adjustment for potential confounders. The RG2 group was also significantly associated with pregnancy induced hypertension, meconium-stained amniotic fluid and premature rupture of membranes. Conclusions: In the study participants, we identified a subgroup (RG2) at high risk of GD with perinatal outcomes showing profile consistent with that of GD.